ImClone Systems

related topics
{company, market, business}
{law, state, case}
{disease, patient, cell}
{son, year, death}
{film, series, show}
{day, year, event}
{government, party, election}
{mi², represent, 1st}

ImClone Systems Incorporated is a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology. It was founded in 1984 and is headquartered in New York City. On October 6, 2008, it accepted a $6.5 billion acquisition offer from Eli Lilly and Company, and became a fully owned subsidiary of Eli Lilly and Company on November 24, 2008. Prior to the acquisition, it was traded on the NASDAQ stock exchange under the symbol IMCL.

Contents

Insider trading scandal

ImClone's stock price dropped sharply at the end of 2001 when its drug Erbitux, an experimental monoclonal antibody failed to get the expected Food and Drug Administration (FDA) approval. It was later revealed by the U.S. Securities and Exchange Commission that numerous executives sold their stock before the announcement of the decision after the close of trading on December 28.

Its founder, Samuel D. Waksal, was arrested in 2002 on insider trading charges for informing friends and family to sell their stock, and attempting to sell his own. His daughter, Aliza Waksal, sold $2.5 million in shares on December 27. His father, Jack Waksal, sold $8.1 million in shares over the 27th and 28th. Company executives had done the same. John B. Landes, the general counsel, sold $2.5 million in shares on December 6. Ronald A. Martell, the vice president for marketing and sales, sold $2.1 million in shares on December 11. Four other executives sold shares in the following weeks as well. Later, Samuel Waksal pleaded guilty to various charges, including securities fraud, and on June 10, 2003, was sentenced to seven years and three months in prison.

Martha Stewart, the founder of Martha Stewart Living Omnimedia (Waksal had dated Stewart's daughter) also became embroiled in the scandal after it emerged that she sold about $230,000 in ImClone shares on December 27, just a day before the announcement of FDA decision. Although Stewart maintained her innocence, she was found guilty and sentenced on July 16, 2004 to five months in prison, five months of home confinement, and two years probation for lying about a stock sale, conspiracy, and obstruction of justice.

Full article ▸

related documents
Federal Energy Regulatory Commission
Chief financial officer
Price fixing
Robinson-Patman Act
Government-granted monopoly
IG Farben
Liability
Network Rail
Economy of the United States Virgin Islands
Big Business
Bunge Limited
Economy of Guam
Economy of Chad
World Food Programme
Mitsubishi
Credit money
Economy of Mauritania
Economy of the Isle of Man
Economy of the Bahamas
European Bank for Reconstruction and Development
Panasonic Corporation
Economy of Guinea-Bissau
Communications in Sudan
ARCO
Bookkeeping
Exxon
Economy of Tuvalu
Gratis
United States Department of Agriculture
Ronald Coase